You are a healthcare industry player (pharmaceutical laboratories, medtechs, biotechs...)
We help you enrich clinical trials and regulatory dossiers by virtually simulating scenarios that cannot be tested in the field, or are difficult to test.
- For your Phase III clinical trials, we support you in the sizing and design of the control arm.
- During the MAA phase, we help deepen your study and highlight all the impacts (medical, economic, organizational) of your innovation to the authorities.
- In phase IV, we help you anticipate the organizational transformations brought about by innovation
You are a public institution (HAS, ARS, GRADeS, etc.) or a healthcare provider (GHT, hospitals, clinics, etc.)
We help you anticipate and objectify the organizational impacts of an innovation or a new care organization through simulation.
- Measure the impacts of organizational, therapeutic, and material innovations on care pathways and department operations.
- Optimize care pathways, hospital logistics, and the healthcare offering in a given region
- Anticipate risks
- Manage in real time taking into account resource, quality and cost constraints